GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optimi Health Corp (OTCPK:OPTHF) » Definitions » Research & Development

OPTHF (Optimi Health) Research & Development : $0.14 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Optimi Health Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Optimi Health's Research & Development for the three months ended in Dec. 2024 was $0.14 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was $0.14 Mil.

Optimi Health Research & Development Historical Data

The historical data trend for Optimi Health's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optimi Health Research & Development Chart

Optimi Health Annual Data
Trend Sep20 Sep21 Sep22 Sep23 Sep24
Research & Development
- 0.19 0.10 0.11 0.11

Optimi Health Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.01 - - 0.14

Optimi Health Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.14 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Optimi Health  (OTCPK:OPTHF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Optimi Health Research & Development Related Terms

Thank you for viewing the detailed overview of Optimi Health's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Optimi Health Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optimi Health Corp (OTCPK:OPTHF) » Definitions » Research & Development
Comparable Companies
XCNQ:RWB XCNQ:FFNT TSX:CWEB TSXV:CANB XCNQ:CLC XCNQ:TRIP TSX:AVNT TSX:CTX TSXV:PCLO XCNQ:QNTM ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
8BN:Germany OPTI:Canada
Address
21 Water Street, Suite 600, Vancouver, BC, CAN, V6B 1A1
Website
https://www.optimihealth.ca
Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribution of raw mushroom biomass. It also intends to cultivate, extract, process, and distribute strains of fungi products at its facilities located in Princeton, British Columbia.